British Association for Psychopharmacology

The British Association for Psychopharmacology (BAP) is a leading learned society and registered charity dedicated to advancing research and education in the fields of psychopharmacology and neuroscience. Established in 1974, BAP stands as the largest national association of its kind in Europe and the second largest globally. The organization unites professionals from academia, health services, and industry, focusing on the neuropsychobiological foundations of brain function and its relationship to mental disorders.

BAP offers a variety of educational resources, including a renowned Journal of Psychopharmacology, a Certificate in Clinical Psychopharmacology, and specialized masterclasses aimed at enhancing clinical knowledge. The association organizes annual meetings featuring lectures, symposiums, and poster sessions to foster scientific discourse. Additionally, BAP promotes public engagement through workshops and participation in science festivals, ensuring accessibility to its findings and guidelines. With a commitment to inclusivity and democratic governance, BAP values contributions from both clinical and non-clinical researchers, striving to improve treatments for mental health conditions.